In subjects with MCI, cerebrospinal fluid and plasma levels of CCL2 are significantly elevated, and CCL2 may serve as a prognostic biomarker for the rate of cognitive decline in patients with MCI (49, 50). Here, CCL2 is linked to Mental deterioration.